AlphaFold predicted structure
NNT · Q13423

Mean pLDDT
90.9/ 100
Very high
1,086 residues
Confidence breakdown
- Very high(≥ 90)80%
- Confident(70–90)14%
- Low(50–70)2%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
nicotinamide nucleotide transhydrogenase
Annotations refreshed 11 hours ago.
Diagnostic Grade (Green)
Congenital adrenal hypoplasia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
Possible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalfamilial glucocorticoid deficiency
neurodegenerative disease
hereditary disease
atypical hemolytic-uremic syndrome with DGKE deficiency
Abnormality of the skeletal system
Cytomegalic congenital adrenal hypoplasia
inborn mitochondrial metabolism disorder
mitochondrial disease
Barrett esophagus
orofacial cleft
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NAD(P) transhydrogenase, mitochondrial
The transhydrogenation between NADH and NADP is coupled to respiration and ATP hydrolysis and functions as a proton pump across the membrane (By similarity). May play a role in reactive oxygen species (ROS) detoxification in the adrenal gland (PubMed:22634753)
NNT · Q13423

Mean pLDDT
90.9/ 100
Very high
1,086 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0